Basit öğe kaydını göster

The effect of combined delivery of recombinant human bone morphogenetic protein-2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium-phosphate-coated implants on osseointegration

dc.contributor.authorvon Wilmowsky, Cornelius
dc.contributor.authorRamazanoglu, Mustafa
dc.contributor.authorErgun, Celaletdin
dc.contributor.authorNkenke, Emeka
dc.contributor.authorSchlegel, Karl Andreas
dc.contributor.authorLutz, Rainer
dc.date.accessioned2021-03-06T13:10:37Z
dc.date.available2021-03-06T13:10:37Z
dc.date.issued2011
dc.identifier.citationRamazanoglu M., Lutz R., Ergun C., von Wilmowsky C., Nkenke E., Schlegel K. A. , "The effect of combined delivery of recombinant human bone morphogenetic protein-2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium-phosphate-coated implants on osseointegration", CLINICAL ORAL IMPLANTS RESEARCH, cilt.22, ss.1433-1439, 2011
dc.identifier.issn0905-7161
dc.identifier.otherav_f75eeff6-615c-4ebe-9927-bdfecc9e58ea
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/162060
dc.identifier.urihttps://doi.org/10.1111/j.1600-0501.2010.02133.x
dc.description.abstractObjectives: The delivery of growth factors for enhanced osseointegration depends on the effectiveness of the carrier systems at the boneimplant interface. This study evaluated the effect of solo and dual delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2) and recombinant human vascular endothelial growth factor (rhVEGF165) from biomimetically octacalcium phosphate-coated implants on osseointegration.
dc.language.isoeng
dc.subjectDiş Hekimliği
dc.subjectBiyomedikal Mühendisliği
dc.subjectMühendislik ve Teknoloji
dc.subjectMühendislik, Bilişim ve Teknoloji (ENG)
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectMühendislik
dc.subjectMÜHENDİSLİK, BİYOMEDİKSEL
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectDİŞ HEKİMLİĞİ, ORAL CERRAHİ VE TIP
dc.titleThe effect of combined delivery of recombinant human bone morphogenetic protein-2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium-phosphate-coated implants on osseointegration
dc.typeMakale
dc.relation.journalCLINICAL ORAL IMPLANTS RESEARCH
dc.contributor.departmentUniversity of Erlangen Nuremberg , ,
dc.identifier.volume22
dc.identifier.issue12
dc.identifier.startpage1433
dc.identifier.endpage1439
dc.contributor.firstauthorID77775


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster